ArticleRedox biology2022

TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.

Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.